Citation
Machigashira, Seiro, et al. "The Protective Effect of Fish Oil Lipid Emulsions On Intestinal Failure-associated Liver Disease in a Rat Model of Short-bowel Syndrome." Pediatric Surgery International, vol. 34, no. 2, 2018, pp. 203-209.
Machigashira S, Kaji T, Onishi S, et al. The protective effect of fish oil lipid emulsions on intestinal failure-associated liver disease in a rat model of short-bowel syndrome. Pediatr Surg Int. 2018;34(2):203-209.
Machigashira, S., Kaji, T., Onishi, S., Yamada, W., Yano, K., Yamada, K., Masuya, R., Kawano, T., Nakame, K., Mukai, M., & Ieiri, S. (2018). The protective effect of fish oil lipid emulsions on intestinal failure-associated liver disease in a rat model of short-bowel syndrome. Pediatric Surgery International, 34(2), 203-209. https://doi.org/10.1007/s00383-017-4190-4
Machigashira S, et al. The Protective Effect of Fish Oil Lipid Emulsions On Intestinal Failure-associated Liver Disease in a Rat Model of Short-bowel Syndrome. Pediatr Surg Int. 2018;34(2):203-209. PubMed PMID: 29039050.
TY - JOUR
T1 - The protective effect of fish oil lipid emulsions on intestinal failure-associated liver disease in a rat model of short-bowel syndrome.
AU - Machigashira,Seiro,
AU - Kaji,Tatsuru,
AU - Onishi,Shun,
AU - Yamada,Waka,
AU - Yano,Keisuke,
AU - Yamada,Koji,
AU - Masuya,Ryuta,
AU - Kawano,Takafumi,
AU - Nakame,Kazuhiko,
AU - Mukai,Motoi,
AU - Ieiri,Satoshi,
Y1 - 2017/10/16/
PY - 2017/09/21/accepted
PY - 2017/10/19/pubmed
PY - 2018/7/17/medline
PY - 2017/10/18/entrez
KW - Fish oil
KW - Intestinal failure-associated liver disease
KW - Short-bowel syndrome
KW - Soy bean oil
SP - 203
EP - 209
JF - Pediatric surgery international
JO - Pediatr Surg Int
VL - 34
IS - 2
N2 - PURPOSE: Pediatric patients with intestinal failure need long-term parenteral nutrition (PN), but this nutritional support causes liver dysfunction, such as intestinal failure-associated liver disease (IFALD). Several studies have shown that the lipid emulsion produced by soybean oil (SO) is associated with the occurrence of IFALD. In this study, we evaluated the effect of SO and fish oil (FO) lipid emulsion on hepatic steatosis. METHODS: Sprague-Dawley rats underwent jugular vein catheterization and were divided into three groups: sham operation with normal chow (Sham group), 80% small bowel resection (80% SBR) + TPN with SO lipid emulsion (SO group), and 80% SBR + TPN with FO lipid emulsion (FO group). All rats were euthanized and the serum biochemistry and hepatic histology analyzed. RESULTS: No significant differences in the serum liver or biliary enzymes were noted between the SO and FO groups. The pathological findings and NAFLD score in the FO group did not show steatosis and were significantly lower than in the SO group. An analysis of the fatty acids profile in the both the SO and FO groups did not indicate essential fatty acid deficiency (EFAD). CONCLUSION: FO lipid emulsion may have a protective role against steatosis of IFALD without EFAD.
SN - 1437-9813
UR - https://www.unboundmedicine.com/medline/citation/29039050/The_protective_effect_of_fish_oil_lipid_emulsions_on_intestinal_failure_associated_liver_disease_in_a_rat_model_of_short_bowel_syndrome_
DB - PRIME
DP - Unbound Medicine
ER -